The global market for Rosai-Dorfman Disease (RDD) Therapeutics is on an upward trajectory, projected to reach USD 839.95 million by 2033, growing at a robust CAGR of 6.9% from 2023 to 2033. The market, valued at USD 431 million in 2023, has previously demonstrated steady growth with a CAGR of 3.3% from 2018 to 2022. …